AML

Aveo gives up on ficlatuzumab in acute myeloid leukemia, citing COVID-19
Fierce Biotech
Mon, 03/30/20 - 10:33 am
Aveo Oncology
ficlatuzumab
AML
COVID-19
clinical trials
AbbVie announces positive topline results from phase 3 trial of VENCLEXTA, Azacitidine combo in AML
Pharmaceutical Business Review
Tue, 03/24/20 - 10:45 am
AbbVie
Venclexta
azacitidine
clinical trials
AML
AbbVie, Roche's Venclexta nails confirmatory combo trial in AML after flopping earlier study
Fierce Pharma
Mon, 03/23/20 - 11:53 am
AbbVie
Roche
Venclexta
AML
clinical trials
AbbVie, Roche's Venclexta endangers AML approval with flopped confirmatory trial
Fierce Pharma
Mon, 03/2/20 - 11:07 pm
AbbVie
Roche
Venclexta
AML
blood cancer
FDA
Study: Common, Inexpensive Drug Could Treat Resistant AML
BioSpace
Tue, 01/21/20 - 11:55 am
AML
cytarabine
hydroxyurea
Following Strong Phase III Results, BMS Plans to Seek Approval for AML Candidate CC-486
BioSpace
Tue, 12/10/19 - 11:38 pm
Bristol-Myers Squibb
CC-486
AML
This Small-Cap Biotech Rose as Much as 98.3% Today
Motley Fool
Mon, 12/9/19 - 11:30 pm
Forty Seven
ASH2019
magrolimab
monoclonal antibodies
AML
FDA slaps a hold on an AML trial as Marker scraps a failing ovarian cancer program, sinking shares
Endpoints
Thu, 11/14/19 - 07:29 pm
Marker Therapeutics
AML
ovarian cancer
clinical trials
FDA
Astellas maintains lead over Daiichi Sankyo with CHMP okay for Xospata
Pharmaforum
Sun, 09/22/19 - 11:02 pm
Astellas
AML
Xospata
Europe
Daiichi Sankyo
Astellas' AML drug wins over CHMP — strengthening lead on Daiichi Sankyo
Endpoints
Fri, 09/20/19 - 10:40 pm
Astellas
FDA
gilteritinib
Europe
AML
Daiichi Sankyo
Roche and Celgene set for battle in acute myelogenous leukaemia
EP Vantage
Wed, 09/18/19 - 09:54 am
Celgene
Roche
AML
acute myeloid leukemia
CC-486
Venclexta
Celgene's AML drug clears late-stage test
Endpoints
Mon, 09/16/19 - 09:17 am
Celgene
AML
CC-486
acute myeloid leukemia
Next up for GlycoMimetics after tanking in sickle cell disease
BioCentury
Mon, 08/5/19 - 10:32 pm
GlycoMimetics
AML
uproleselan
BerGenBio posts updated data on trial of elderly AML patients
Fierce Biotech
Fri, 06/14/19 - 10:12 am
BerGenBio
bemcentinib
AML
acute myeloid leukemia
AACR: Astellas pads Xospata's AML lead with chemo-beating survival data
Fierce Pharma
Mon, 04/1/19 - 12:38 pm
Astellas
Xospata
acute myeloid leukemia
AML
AACR
FDA stamps fast OK on Astellas' pioneering FLT3 AML drug gilteritinib, expanding on a record year for new approvals
Endpoints
Thu, 11/29/18 - 12:10 am
Astellas
FDA
AML
Xospata
gilteritinib
AbbVie, Roche aim to face down Pfizer with Venclexta’s move into AML arena
Fierce Pharma
Mon, 11/26/18 - 12:35 pm
AbbVie
Venclexta
Roche
AML
Playing a hot hand in cancer R&D, Pfizer scores its 4th drug approval in just 2 months
Endpoints
Sat, 11/24/18 - 01:30 pm
Pfizer
FDA
glasdegib
acute myeloid leukemia
AML
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
Yahoo/Guru Focus
Sat, 11/24/18 - 01:27 pm
Roche
Genentech
Venclexta
FDA
AML
acute myeloid leukemia
Trovagene Receives Orphan Drug Designation for Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
CP Wire
Wed, 08/29/18 - 12:42 pm
TrovaGene
Onvansertib
AML
mCRPC
non-Hodgkin lymphoma
triple negative breast cancer

Pages